Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-06-0658
European Journal of Endocrinology, Vol 156, Issue 5, 603-610
Copyright © 2007 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dieterle, C. D
Right arrow Articles by Landgraf, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dieterle, C. D
Right arrow Articles by Landgraf, R.

CLINICAL STUDY

Metabolic follow-up after long-term pancreas graft survival

Christoph D Dieterle, Helmut Arbogast1, Wolf-Dieter Illner1, Susanne Schmauss and Rüdiger Landgraf

1 Diabetes Centre, Medizinische Klinik Innenstadt, University of Munich, 80336 Munich, Germany, 2Transplant Surgery, Department of Surgery, Klinikum Grosshadern, University of Munich, 81377 Munich, Germany

(Correspondence should be addressed to C D Dieterle; Email: christoph.dieterle{at}med.uni-muenchen.de)

Design: Successful pancreas transplantation results in insulin independence and normoglycemia. This prospective study was performed to investigate long-term metabolic changes after pancreas transplantation.

Methods: Thirty-eight type 1 diabetic patients after simultaneous pancreas/kidney transplantation (SPK) with a pancreas graft survivalfor at least10years were studied in a prospective manner. HbA1c and glucose levels before and during an oral glucose tolerance test (OGTT) were analyzed from 3 months to 10 years after SPK. In addition, insulin secretion and glucagon response were measured.

Results: Fasting glucose increased slightly and continuously from 3 months to 10 years (from 78 ± 3 to 91 ± 2 mg/dl). Even HbA1c levels showed a mild but significant increase from 3 months to 10 years after SPK. Glucose tolerance deteriorated markedly 10 years after SPK. Insulin secretion during OGTT remained stable for 10 years. Parameters of insulin resistance and sensitivity did not change significantly but glucagon secretion increased significantly during the course after SPK. Late after SPK, glucagon levels were higher in patients with an impaired or diabetic glucose tolerance.

Conclusions: Pancreas transplantation is able to restore endogenous insulin secretion for 10 years or more. Especially, late after SPK, a deterioration of glycemic control was detected, even if glucose values were within the normal range. During prospective long-term follow-up, an increase of glucagon secretion but no decrease of insulin secretion was detected.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 European Society of Endocrinology.